Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 25.11%1.44B | 35.58%933.87M | 43.74%443.41M | 23.71%1.63B | 16.91%1.15B | -3.85%688.81M | -12.27%308.47M | -0.25%1.32B | 3.93%981.23M | 716.41M |
Operating revenue | 25.11%1.44B | 35.58%933.87M | 43.74%443.41M | 23.71%1.63B | 16.91%1.15B | -3.85%688.81M | -12.27%308.47M | -0.25%1.32B | 3.93%981.23M | --716.41M |
Total operating cost | 31.60%1.19B | 31.90%755.74M | 29.57%360.24M | 24.93%1.25B | 24.38%902.09M | 10.58%572.96M | 5.05%278.02M | 2.15%1B | 725.3M | 518.13M |
Operating cost | 29.80%973.72M | 32.34%626.94M | 33.13%293.67M | 31.26%1.05B | 29.09%750.19M | 15.56%473.74M | 8.57%220.59M | 1.69%797.97M | --581.15M | --409.96M |
Operating tax surcharges | 10.95%12.17M | 28.95%8.01M | 203.68%4.82M | 116.39%12.66M | 164.92%10.97M | 125.38%6.21M | 12.78%1.59M | 6.74%5.85M | --4.14M | --2.76M |
Operating expense | 52.91%9.6M | 25.96%5.94M | -14.19%1.58M | 1.48%10.29M | -8.63%6.28M | 1.16%4.71M | 13.51%1.84M | 20.31%10.14M | --6.87M | --4.66M |
Administration expense | 32.87%92.34M | 43.29%61.27M | 81.25%35.99M | 38.71%99.75M | 20.55%69.49M | 9.87%42.76M | -7.52%19.86M | 13.53%71.92M | --57.65M | --38.92M |
Financial expense | -3.29%-10.44M | -403.82%-14.63M | -158.87%-6.64M | -222.17%-22.15M | -1,252.93%-10.1M | -126.55%-2.9M | -13.01%11.27M | -44.30%18.13M | --876.3K | --10.94M |
-Interest expense (Financial expense) | -49.90%11.57M | -52.48%8.2M | -52.02%4.65M | -49.10%21.42M | -26.21%23.1M | -34.17%17.25M | -24.90%9.69M | -0.70%42.08M | --31.3M | --26.2M |
-Interest Income (Financial expense) | 6.78%-26.39M | -21.89%-20.22M | -196.37%-11.32M | -273.62%-41.43M | -334.00%-28.32M | -435.56%-16.59M | -171.82%-3.82M | -137.04%-11.09M | ---6.52M | ---3.1M |
Research and development | 45.84%109.76M | 40.85%68.21M | 34.73%30.81M | 6.39%106.29M | 0.88%75.26M | -4.85%48.43M | -4.85%22.87M | 13.26%99.91M | --74.61M | --50.9M |
Credit Impairment Loss | 93.18%-94.17K | 37.06%-355.67K | -253.65%-898.78K | -288.27%-1.1M | -210.45%-1.38M | -173.65%-565.07K | ---254.14K | 193.22%584.95K | --1.25M | --767.22K |
Asset Impairment Loss | -208.14%-4.16M | -105.09%-3.94M | -5.01%-384.01K | 44.22%-3.75M | 69.30%-1.35M | 48.95%-1.92M | 23.50%-365.69K | -47.94%-6.72M | ---4.4M | ---3.77M |
Other net revenue | ||||||||||
Fair value change income | -65.71%268.63K | -34.62%23.7K | 114.10%220.73K | -72.16%21.46K | 793.43%783.46K | -54.96%36.25K | --103.1K | --77.09K | --87.69K | --80.47K |
Invest income | 79.14%5.14M | 221.06%3.14M | 90.88%1M | -1.76%4.78M | -21.49%2.87M | -51.93%978.52K | --524.52K | 128.24%4.86M | --3.66M | --2.04M |
Asset deal income | --1.01M | --1.01M | ---- | ---- | ---- | ---- | ---- | -100.11%-889.45 | ---889.45 | ---889.45 |
Other revenue | -24.78%18.76M | -35.08%11.87M | 92.12%5.64M | 165.04%47.44M | 57.88%24.94M | 696.49%18.28M | 15.52%2.93M | 26.94%17.9M | --15.8M | --2.29M |
Operating profit | -0.70%269.08M | 43.13%189.87M | 165.69%88.74M | 28.08%422.49M | -0.49%270.99M | -33.57%132.66M | -62.47%33.4M | -5.61%329.86M | 12.07%272.33M | 199.69M |
Add:Non operating Income | -94.90%511.92K | -99.52%29.89K | 8.96%1.02M | -67.54%2.81M | 29.15%10.05M | 12.76%6.28M | --931.84K | 199.29%8.66M | --7.78M | --5.57M |
Less:Non operating expense | -13.50%1.94M | 37.03%1.3M | 119.82%530.68K | 808.16%6.64M | 209.24%2.24M | 1,086.79%948.91K | 2,263.09%241.41K | -19.59%730.62K | --724.7K | --79.96K |
Total profit | -3.99%267.66M | 36.68%188.6M | 161.73%89.23M | 23.95%418.67M | -0.21%278.79M | -32.75%137.99M | -61.69%34.09M | -3.88%337.78M | 14.88%279.39M | 205.18M |
Less:Income tax cost | 16.03%39.26M | 68.59%26.58M | 260.46%12.54M | 35.83%47.01M | 3.93%33.83M | -35.41%15.77M | -70.28%3.48M | -16.84%34.61M | --32.55M | --24.41M |
Net profit | -6.76%228.4M | 32.57%162.02M | 150.51%76.69M | 22.59%371.66M | -0.76%244.96M | -32.39%122.22M | -60.39%30.61M | -2.14%303.18M | 14.21%246.83M | 180.77M |
Net profit from continuing operation | -6.76%228.4M | 32.57%162.02M | 150.51%76.69M | 22.59%371.66M | -0.76%244.96M | -32.39%122.22M | -60.39%30.61M | -2.14%303.18M | --246.83M | --180.77M |
Net profit of parent company owners | -6.76%228.4M | 32.57%162.02M | 150.51%76.69M | 22.59%371.66M | -0.76%244.96M | -32.39%122.22M | -60.39%30.61M | -0.49%303.18M | 17.00%246.83M | --180.77M |
Earning per share | ||||||||||
Basic earning per share | -13.64%0.19 | 16.67%0.14 | 100.00%0.06 | 6.45%0.33 | -12.00%0.22 | -33.33%0.12 | -62.50%0.03 | 0.00%0.31 | --0.25 | --0.18 |
Diluted earning per share | -13.64%0.19 | 16.67%0.14 | 100.00%0.06 | 6.45%0.33 | -12.00%0.22 | -33.33%0.12 | -62.50%0.03 | 0.00%0.31 | --0.25 | --0.18 |
Other composite income | -132.32%-236.23K | -81.10%155.49K | 116.99%38.14K | -73.77%369.28K | -64.57%731K | -8.44%822.66K | 77.02%-224.52K | 749.80%1.41M | 2.06M | 898.51K |
Other composite income of parent company owners | -132.32%-236.23K | -81.10%155.49K | 116.99%38.14K | -73.77%369.28K | -64.57%731K | -8.44%822.66K | 77.02%-224.52K | 749.80%1.41M | --2.06M | --898.51K |
Total composite income | -7.13%228.17M | 31.81%162.18M | 152.48%76.73M | 22.14%372.03M | -1.29%245.69M | -32.27%123.04M | -60.18%30.39M | -1.62%304.58M | 248.9M | 181.67M |
Total composite income of parent company owners | -7.13%228.17M | 31.81%162.18M | 152.48%76.73M | 22.14%372.03M | -1.29%245.69M | -32.27%123.04M | -60.18%30.39M | 0.04%304.58M | --248.9M | --181.67M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.